These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11469638)

  • 1. Hypoglycemia and the hypoglycemic unawareness syndrome.
    Hirsch IB
    Diabetes Technol Ther; 2000; 2 Suppl 1():S81-7. PubMed ID: 11469638
    [No Abstract]   [Full Text] [Related]  

  • 2. Durable reversal of hypoglycemia unawareness in type 1 diabetes.
    Dagogo-Jack S; Fanelli CG; Cryer PE
    Diabetes Care; 1999 May; 22(5):866-7. PubMed ID: 10332708
    [No Abstract]   [Full Text] [Related]  

  • 3. Syndrome of hypoglycemia unawareness when changing insulin species.
    Daneman D; Zinman B
    Diabetes Care; 1991 Feb; 14(2):145-6. PubMed ID: 2060420
    [No Abstract]   [Full Text] [Related]  

  • 4. Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes.
    Kinsley BT; Weinger K; Bajaj M; Levy CJ; Simonson DC; Quigley M; Cox DJ; Jacobson AM
    Diabetes Care; 1999 Jul; 22(7):1022-8. PubMed ID: 10388961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypoglycemia--simply annoying or dangerous?].
    Kern W
    MMW Fortschr Med; 2016 Jun; 158(11):67-70. PubMed ID: 27271419
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin glargine: commentary on the duration of action and lower risk of nocturnal hypoglycaemia in patients with diabetes.
    Rosenstock J; Owens D
    Expert Opin Pharmacother; 2004 Jan; 5(1):1-2; author reply 2-3. PubMed ID: 14680430
    [No Abstract]   [Full Text] [Related]  

  • 7. Preserved sensitivity to beta2-adrenergic receptor agonists in patients with type 1 diabetes mellitus and hypoglycemia unawareness.
    De Galan BE; De Mol P; Wennekes L; Schouwenberg BJ; Smits P
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2878-81. PubMed ID: 16705070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus.
    Hemmingsen B; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013498. PubMed ID: 33662147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient experience of hypoglycaemia unawareness in Type 1 diabetes: are patients appropriately concerned?
    Rogers HA; de Zoysa N; Amiel SA
    Diabet Med; 2012 Mar; 29(3):321-7. PubMed ID: 21913969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia.
    ter Braak EW; Appelman AM; van de Laak M; Stolk RP; van Haeften TW; Erkelens DW
    Diabetes Care; 2000 Oct; 23(10):1467-71. PubMed ID: 11023138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar A1C outcomes in type 1 diabetic patients undergoing intensive diabetes management with preprandial rapid-acting insulin and either CSII or glargine.
    Harmel AP; Mathur R
    Diabetes Care; 2004 Jan; 27(1):272-3. PubMed ID: 14694001
    [No Abstract]   [Full Text] [Related]  

  • 12. Association between hypoglycemia and the type of insulin in diabetic patients treated with multiple injections: an observational study.
    Wróbel MP; Wystrychowski G; Psurek A; Szymborska-Kajanek A; Strojek K
    Pol Arch Med Wewn; 2014; 124(4):173-9. PubMed ID: 24727596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoglycemia. Frequency, severity, and consequences.
    Brouhard BH
    Diabetes Care; 1992 Apr; 15(4):582-3. PubMed ID: 1499486
    [No Abstract]   [Full Text] [Related]  

  • 14. [Different strategies in prediabetes, new and long-time diabetes. What therapy for what diabetics?].
    Stiefelhagen P
    MMW Fortschr Med; 2010 Jan; 152(3):12-4, 16. PubMed ID: 20333958
    [No Abstract]   [Full Text] [Related]  

  • 15. Glycaemic control and hypoglycaemia in children, adolescents and young adults with unstable type 1 diabetes mellitus treated with insulin glargine or intermediate-acting insulin.
    Herwig J; Scholl-Schilling G; Böhles H
    J Pediatr Endocrinol Metab; 2007 Apr; 20(4):517-25. PubMed ID: 17550216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fear of hypoglycemia.
    Bloomgarden Z
    J Diabetes; 2017 Feb; 9(2):108-110. PubMed ID: 27736014
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing impaired hypoglycemia awareness in type 1 diabetes: agreement of self-report but not of field study data with the autonomic symptom threshold during experimental hypoglycemia.
    Janssen MM; Snoek FJ; Heine RJ
    Diabetes Care; 2000 Apr; 23(4):529-32. PubMed ID: 10857947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: a systematic review and meta-analysis.
    Benkhadra K; Alahdab F; Tamhane SU; McCoy RG; Prokop LJ; Murad MH
    Endocrine; 2017 Jan; 55(1):77-84. PubMed ID: 27477293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do high fasting glucose levels suggest nocturnal hypoglycaemia? The Somogyi effect-more fiction than fact?
    Choudhary P; Davies C; Emery CJ; Heller SR
    Diabet Med; 2013 Aug; 30(8):914-7. PubMed ID: 23672623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoglycemia unawareness is associated with reduced adherence to therapeutic decisions in patients with type 1 diabetes: evidence from a clinical audit.
    Smith CB; Choudhary P; Pernet A; Hopkins D; Amiel SA
    Diabetes Care; 2009 Jul; 32(7):1196-8. PubMed ID: 19389817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.